pentamidine has been researched along with mycophenolic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benedicto, B; Beshbishy, AM; Galon, EM; Gao, Y; Guo, H; Igarashi, I; Ji, S; Lee, SH; Li, J; Li, Y; Liu, M; Moumouni, PFA; Nugraha, AB; Rizk, MA; Tumwebaze, MA; Xuan, X; Yokoyama, N | 1 |
1 review(s) available for pentamidine and mycophenolic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for pentamidine and mycophenolic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Drug screening of food and drug administration-approved compounds against Babesia bovis in vitro.
Topics: Animals; Antiprotozoal Agents; Babesia bovis; Babesiosis; Cattle; Cattle Diseases; Dogs; Doxorubicin; Drug Approval; Drug Combinations; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Mycophenolic Acid; Pentamidine; Small Molecule Libraries; Spectrometry, Fluorescence; Vorinostat | 2020 |